140 related articles for article (PubMed ID: 38292582)
1. Successful use of dupilumab in recalcitrant pediatric atopic dermatitis-like graft-versus-host disease: A case series.
Belmesk L; Hatami A; Powell J; Kokta V; Coulombe J
JAAD Case Rep; 2024 Feb; 44():11-16. PubMed ID: 38292582
[No Abstract] [Full Text] [Related]
2. Atopic dermatitis-like graft-versus-host disease treated with dupilumab.
Larijani M; Zarowin D; Wohlschlaeger A; Perman MJ; Treat JR
Pediatr Dermatol; 2023 Mar; 40(2):320-322. PubMed ID: 36268606
[TBL] [Abstract][Full Text] [Related]
3. Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series.
Deng L; Luo Y; An B; Su M; Sang H; Liu F
Clin Cosmet Investig Dermatol; 2022; 15():2421-2426. PubMed ID: 36387965
[TBL] [Abstract][Full Text] [Related]
4. Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series.
Slodownik D; Levi A; Lapidoth M; Moshe S
Dermatology; 2022; 238(6):1073-1075. PubMed ID: 35462358
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab after the 2017 approval for the treatment of atopic dermatitis: what's new and what's next?
van der Schaft J; Thijs JL; de Bruin-Weller MS; Balak DMW
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):341-349. PubMed ID: 31145194
[TBL] [Abstract][Full Text] [Related]
6. The Application of Dupilumab to Pediatric Patients Aged 6-11yrs with Moderate-to-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled: The Clinical Data so Far.
Balboul S; Kahn J; Tracy A; Peacock A; Cline A
Drug Des Devel Ther; 2023; 17():1323-1327. PubMed ID: 37152103
[TBL] [Abstract][Full Text] [Related]
7. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis.
Maloney NJ; Tegtmeyer K; Zhao J; Worswick S
J Drugs Dermatol; 2019 Oct; 18(10):. PubMed ID: 31603635
[TBL] [Abstract][Full Text] [Related]
9. Rosacea associated with dupilumab therapy.
Heibel HD; Hendricks AJ; Foshee JP; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
[No Abstract] [Full Text] [Related]
10. Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020.
Martinez-Cabriales SA; Kirchhof MG; Constantinescu CM; Murguia-Favela L; Ramien ML
Am J Clin Dermatol; 2021 Jul; 22(4):443-455. PubMed ID: 34076879
[TBL] [Abstract][Full Text] [Related]
11. Increased regulatory T cells and eosinophils characterize atopic dermatitis-like graft-versus-host disease compared with lichen planus-like graft-versus-host disease.
Li K; Mu Z; Wen G; Zhao Y; Cong X; Zhang J
J Am Acad Dermatol; 2020 Sep; 83(3):824-831. PubMed ID: 31404571
[TBL] [Abstract][Full Text] [Related]
12. Safety of dupilumab in patients with atopic dermatitis: expert opinion.
Francuzik W; Alexiou A; Worm M
Expert Opin Drug Saf; 2021 Sep; 20(9):997-1004. PubMed ID: 34114910
[No Abstract] [Full Text] [Related]
13. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
Bansal A; Simpson EL; Paller AS; Siegfried EC; Blauvelt A; de Bruin-Weller M; Corren J; Sher L; Guttman-Yassky E; Chen Z; Daizadeh N; Kamal MA; Shumel B; Mina-Osorio P; Mannent L; Patel N; Graham NMH; Khokhar FA; Ardeleanu M
Am J Clin Dermatol; 2021 Jan; 22(1):101-115. PubMed ID: 33481203
[TBL] [Abstract][Full Text] [Related]
14. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab.
Ungar B; Glickman JW; Golant AK; Dubin C; Marushchak O; Gontzes A; Mikhaylov D; Singer GK; Baum D; Wei N; Sanin A; Gruenstein D; Lebwohl MG; Pavel AB; Guttman-Yassky E
J Allergy Clin Immunol Pract; 2022 Jan; 10(1):134-142. PubMed ID: 34737108
[TBL] [Abstract][Full Text] [Related]
16. The use of dupilumab in severe atopic dermatitis during pregnancy: a case report.
Akhtar NH; Khosravi-Hafshejani T; Akhtar D; Dhadwal G; Kanani A
Allergy Asthma Clin Immunol; 2022 Feb; 18(1):9. PubMed ID: 35115035
[TBL] [Abstract][Full Text] [Related]
17. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients.
Guex-Crosier Y; Di-Lucca J; Häusermann P; Laffitte E; Saulite I; Schmid-Grendelmeier P; Schürch K; Thormann K; Simon D
Swiss Med Wkly; 2021 Aug; 151():w30020. PubMed ID: 34495603
[TBL] [Abstract][Full Text] [Related]
18. Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report.
Kurokawa Y; Oikawa Y; Shimada A; Yajima K
Diabetol Int; 2022 Jan; 13(1):300-303. PubMed ID: 35059267
[TBL] [Abstract][Full Text] [Related]
19. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
Yamane MLM; Belsito DV; Glass LRD
Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
[TBL] [Abstract][Full Text] [Related]
20. Ocular surface disease associated with dupilumab treatment for atopic diseases.
Utine CA; Li G; Asbell P; Pflugfelder S; Akpek E
Ocul Surf; 2021 Jan; 19():151-156. PubMed ID: 32439390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
